Related Experiment Video

Updated: Aug 30, 2026

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN
11:50

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN

Published on: April 3, 2026

A big step in the study of small cell lung cancer

John D Minna1, Jonathan M Kurie, Tyler Jacks

  • 1Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. john.minna@utsouthwestern.edu

Cancer Cell
|October 3, 2003
PubMed

Insights

Researchers developed a new mouse model for studying small cell lung cancer (SCLC). This conditional p53 and Rb allele-based, lung-targeted model offers a valuable tool for translational research against SCLC.

Area of Science:

  • Oncology
  • Genetics
  • Translational Medicine

Background:

  • Small cell lung cancer (SCLC) is an aggressive form of lung cancer with limited treatment options.
  • The p53 and Rb tumor suppressor genes play critical roles in SCLC development.
  • Existing mouse models may not fully recapitulate the complexity of human SCLC.

Purpose of the Study:

  • To develop and validate a novel, genetically engineered mouse model for SCLC.
  • To create a lung-targeted model that incorporates conditional p53 and Rb allele-based alterations.
  • To provide a tool for advancing translational research in SCLC.

Main Methods:

  • Rational design of a conditional mouse model.
  • Targeting of p53 and Rb alleles.
  • Lung-specific targeting for SCLC induction.

Main Results:

  • Successful development of a conditional, lung-targeted mouse model.
  • The model accurately reflects key genetic alterations found in human SCLC.
  • The model serves as a valid platform for preclinical studies.

Conclusions:

  • This new mouse model is a significant advancement for SCLC research.
  • It offers a powerful tool for investigating SCLC pathogenesis and testing novel therapies.
  • The model facilitates translational research efforts aimed at combating SCLC.

More Related Videos

Optimized Preparation of Whole Murine Tumor-Bearing Lung Tissue for Flow Cytometry and Single-Cell RNA-Sequencing06:44

Optimized Preparation of Whole Murine Tumor-Bearing Lung Tissue for Flow Cytometry and Single-Cell RNA-Sequencing

Published on: May 22, 2026

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Related Concept Videos